Английская Википедия:Danuglipron

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Infobox drug

Danuglipron is a small-molecule GLP-1 agonist developed by Pfizer[1] that, in an oral formulation, is under investigation as a therapy for diabetes mellitus. Initial results from a randomized controlled trial indicate that it reduced weight and improved diabetic control. The most commonly reported adverse events were nausea, diarrhea, and vomiting.[2][3]

See also

References

Шаблон:Reflist

Шаблон:Oral hypoglycemics and insulin analogs Шаблон:Portal bar Шаблон:Gastrointestinal-drug-stub